LAMTOR5 and systemic lupus erythematosus: Conversely, efficient Lamtor5 binding to v-ATPase limits mTORC1 activity by interfering with Rag/mTORC1 interaction at the lysosomal membrane, which alleviates SLE-like pathology in mice [254].